{"id":"tp-62206","type":"article-newspaper","title":"Savara Shares Fall 18% After Company Says FDA Will Miss Molgramostim Action Date","author":"Riza Dagoc","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/regulation/62206","datePublished":"2026-11-20T16:45:29.000Z","dateModified":"2026-11-20T16:45:29.000Z","language":"en","abstract":"The FDA’s review is ongoing, and the agency has not provided a new action date.","section":"Regulation","references":[]}